Knight Therapeutics | GUD - Acreedores Comerciales

Precio De Mercado
8.66
Cambio Diario
-0.03 -0.35%
Mensual
13.65%
Anual
47.78%
Q2 Expectativa
8.51




Acreedores Comerciales Cambio Fecha
Acasti Pharma USD 459K 881K 2025-09
Akebia Therapeutics USD 8.39M 12.8M 2026-03
Alaunos Therapeutics USD 613K 230K 2025-12
Aurora Cannabis CAD 68.03M 18.68M 2025-12
Avita Medical AUD 8.96M 1.69M 2025-12
Canopy Growth CAD 19.96M 1.83M 2025-12
Cronos Group USD 10.28M 1.36M 2026-03
Dianthus Therapeutics USD 5.27M 4.45M 2026-03
Ionis Pharmaceuticals USD 26.03M 2.05M 2026-03
IQVIA Holdings USD 3.64B 112M 2026-03
Knight Therapeutics CAD 125.76M 7.63M 2025-12
Moderna USD 161M 156M 2026-03
Omeros USD 8.84M 4.42M 2025-06
Organigram Holdings CAD 71.08M 18.17M 2025-12
Organon & Co USD 983M 31M 2026-03
Revvity USD 169.68M 15.78M 2026-03
Tectonic Therapeutic USD 2.55M 1.46M 2026-03
Tilray USD 114.5M 3.69M 2025-09
Viatris USD 1.2B 93.9M 2026-03
Xeris Pharmaceuticals USD 11.47M 8.39M 2026-03